Forbes Medi-Tech Lifted by EU's Reducol Approval
80345
Forbes Medi-Tech Inc.   hit a milestone  on Friday, winning European approval for the use of its  cholesterol-lowering ingredient, Reducol, in milk-based drinks  in the European Union.
380457
European stocks were higher on Wednesday thanks to a strong performance on Wall Street overnight, and fresh merger and acquisition activity.
435314
European stock markets have risen after they were supported by the commodity and airline sectors, a day after surging in response to healthy US growth data.
130935
The health insurer got a boost from its growing government segment, a lower-than-expected income tax rate and a gain on the sale of a venture capital investment.
717777
The approval, which was widely anticipated, triggered at least three analyst upgrades and sent Labopharm's shares up as high as C$4.50 before easing a bit to C$4.09 on the Toronto Stock Exchange, for a gain of ...
520628
European tobacco stocks were lifted by bid activity on Thursday which helped equity markets nudge higher as investors awaited interest rate decisions from both the European Central Bank and the Bank of England.
745892
Sanofi-Aventis said on Friday that  U.S. regulators had approved wider use for its colon cancer  drug Eloxatin, lifting shares in the world's third-largest  pharmaceuticals group.
195987
European stocks were higher on Monday, with heavyweight pharmaceutical, oil and technology stocks leading the charge. The big news early on Monday was that pan-European bourse operator Euronext had confirmed
560715
The regulatory approval was also a boost for the embattled drugs sector. It was feared that, following a series of safety crises, the US Food and Drug Administration would get tougher on new drugs.
371437
dj Orthopedics reaps huge gains after a good sales report.
536698
EU approval opens new markets for the cancer drug that could edge out the competition by lowering overall medical costs.
260929
The med-tech firm impresses on many levels.
457539
European equity markets were higher on Wednesday, lifted by rallying financial stocks and following gains in the US and Asia.
687744
Shares of Boston Scientific (BSX:NYSE - news - research) rose Monday following the announcement that the Food and Drug Administration had approved its product to reduce the risk of a heart attack following heart bypass surgery.
388761
A key Medicare coverage decision, expected as early as Wednesday afternoon, could vastly expand the &#36;4.8 billion market for devices used to resuscitate patients whose hearts are beating out of control, doctors and device maker Medtronic Inc. said on Tuesday.
228350
Roche Holding AG  has overcome Ventana's  resistance to its takeover bid by raising its price, acquiring the diagnostics maker for $3.4 billion to boost its cancer testing business.
309289
Roche Holding, the drug company, has received European Union approval for its colon cancer treatment Avastin.